VentureBeat August 15, 2024
Bryson Masse

Caresyntax has raised $180 million in a Series C extension and debt financing round, the company announced today, further fueling the development and marketing of its “surgical intelligence platform,” a software-as-a-service (Saas) offering that seeks to improve surgery outcomes for patients by connecting the entire surgery process through tech — from booking staff to monitoring the surgery with close-up video to providing analytics about surgery outcomes and costs.

The platform can even connect to other existing robotic surgery tools and equipment found in operating rooms around the world.

Now, the new funding funding builds on Caresyntax’s previous $130 million Series C from 2021 and other sources, bringing its total funding to around $400 million since its founding in 2013.

VentureBeat...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Investments, Medical Devices, Technology, Trends
Phillips launches updated AI tech for MRI scanners
Medtronic partners with Brainomix on AI stroke tool
Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces
Building Solid Relationships with Universities Critical for Early Stage Medtech Investors
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Share This Article